NO2515886T3 - - Google Patents
Info
- Publication number
- NO2515886T3 NO2515886T3 NO10790565A NO10790565A NO2515886T3 NO 2515886 T3 NO2515886 T3 NO 2515886T3 NO 10790565 A NO10790565 A NO 10790565A NO 10790565 A NO10790565 A NO 10790565A NO 2515886 T3 NO2515886 T3 NO 2515886T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09180413 | 2009-12-22 | ||
EP10154648 | 2010-02-25 | ||
PCT/EP2010/069654 WO2011076621A2 (de) | 2009-12-22 | 2010-12-14 | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
EP10790565.5A EP2515886B1 (de) | 2009-12-22 | 2010-12-14 | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2515886T3 true NO2515886T3 (no) | 2018-09-08 |
Family
ID=43383419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO10790565A NO2515886T3 (no) | 2009-12-22 | 2010-12-14 |
Country Status (16)
Country | Link |
---|---|
US (1) | US8962014B2 (no) |
EP (1) | EP2515886B1 (no) |
JP (1) | JP6083734B2 (no) |
KR (1) | KR101674240B1 (no) |
CN (1) | CN102711744B (no) |
AU (1) | AU2010335309B2 (no) |
BR (1) | BR112012017168B1 (no) |
CA (1) | CA2785117C (no) |
CY (1) | CY1120283T1 (no) |
DK (1) | DK2515886T3 (no) |
ES (1) | ES2670227T3 (no) |
MX (1) | MX350357B (no) |
NO (1) | NO2515886T3 (no) |
PL (1) | PL2515886T3 (no) |
PT (1) | PT2515886T (no) |
WO (1) | WO2011076621A2 (no) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
EP2468274B1 (de) * | 2010-12-14 | 2015-07-01 | Acino AG | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
BR112013029945A2 (pt) * | 2011-05-20 | 2017-01-31 | Sk Chemicals Co Ltd | emplastro contendo rivastigmina |
CA2841785A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
CN103796645B (zh) | 2011-08-31 | 2017-06-20 | 东洋油墨Sc控股株式会社 | 贴剂 |
EP2594261A1 (en) | 2011-11-18 | 2013-05-22 | Labtec GmbH | Composition for transdermal administration of rivastigmine |
DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
WO2013128562A1 (ja) | 2012-02-28 | 2013-09-06 | ニチバン株式会社 | 貼付剤 |
US20140083878A1 (en) * | 2012-09-21 | 2014-03-27 | Mylan Inc. | Transdermal drug delivery device |
CN103933018A (zh) * | 2013-01-18 | 2014-07-23 | 江苏康倍得药业有限公司 | 一种透皮给药系统 |
WO2015174502A1 (ja) | 2014-05-15 | 2015-11-19 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
CN106715629B (zh) | 2014-09-23 | 2019-07-12 | 伊奎斯塔化学有限公司 | 聚烯烃基组合物、粘合剂,以及由其制备的相关多层结构 |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
DE102015119789A1 (de) * | 2015-11-16 | 2017-05-18 | Denso-Holding Gmbh & Co. | Korrosionsschutzzusammensetzung umfassend Polyisobutylene |
AU2018205529B2 (en) | 2017-01-06 | 2023-08-10 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
US10646454B2 (en) | 2017-03-24 | 2020-05-12 | E Ink California, Llc | Microcell delivery systems including charged or magnetic particles for regulating rate of administration of actives |
CN110461314A (zh) | 2017-03-24 | 2019-11-15 | 伊英克加利福尼亚有限责任公司 | 用于递送活性分子的微单元系统 |
JP6972334B2 (ja) | 2017-11-14 | 2021-11-24 | イー インク カリフォルニア, エルエルシー | 多孔性伝導電極層を含む電気泳動活性分子送達システム |
JP2021522187A (ja) * | 2018-04-17 | 2021-08-30 | エルテーエス ローマン テラピー−ジステーメ アーゲー | ソリフェナシンの経皮投与のための経皮治療システム |
CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
US11938214B2 (en) | 2019-11-27 | 2024-03-26 | E Ink Corporation | Benefit agent delivery system comprising microcells having an electrically eroding sealing layer |
WO2022093547A1 (en) | 2020-10-29 | 2022-05-05 | E Ink California, Llc | Microcell systems for delivering hydrophilic active molecules |
WO2022093541A1 (en) | 2020-10-29 | 2022-05-05 | E Ink California, Llc | Microcell systems for delivering benefit agents |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU201906B (en) | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
JPS63307818A (ja) * | 1987-06-08 | 1988-12-15 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
JPH07116025B2 (ja) * | 1988-03-11 | 1995-12-13 | 積水化学工業株式会社 | 貼付剤 |
JP2693212B2 (ja) * | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | 疾患治療用テープ製剤 |
JPH08193030A (ja) | 1995-01-12 | 1996-07-30 | Nitto Denko Corp | エメダスチン貼付製剤 |
JPH10152434A (ja) | 1996-09-26 | 1998-06-09 | Nitto Denko Corp | 経皮吸収型製剤 |
GB9800526D0 (en) | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
DE19814087A1 (de) * | 1998-03-30 | 1999-10-14 | Lohmann Therapie Syst Lts | Feuchtigkeitsaktivierbares therapeutisches System |
DE19918106A1 (de) | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
EP1437130A4 (en) * | 2001-10-17 | 2009-08-26 | Hisamitsu Pharmaceutical Co | PERCUTANEOUS ABSORPTION PREPARATIONS |
JP4478757B2 (ja) * | 2002-04-19 | 2010-06-09 | 日東電工株式会社 | ビソプロロール含有貼付剤 |
RU2401125C2 (ru) * | 2004-12-27 | 2010-10-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Способ стабилизации лекарственного средства против деменции |
TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
CN1994290B (zh) * | 2006-01-04 | 2011-03-16 | 上海医药工业研究院 | 卡巴拉汀透皮贴剂及其制备方法 |
KR20090009951A (ko) | 2006-05-08 | 2009-01-23 | 데이고꾸세이약꾸가부시끼가이샤 | 항치매제를 포함하는 경피 흡수 제제 |
US9248104B2 (en) * | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
JP2009022730A (ja) * | 2007-06-18 | 2009-02-05 | Kyoritsu Yakuhin Kogyo Kk | 貼付剤 |
-
2010
- 2010-12-14 CN CN201080059296.4A patent/CN102711744B/zh active Active
- 2010-12-14 PT PT107905655T patent/PT2515886T/pt unknown
- 2010-12-14 KR KR1020127017374A patent/KR101674240B1/ko active IP Right Grant
- 2010-12-14 US US13/518,006 patent/US8962014B2/en active Active
- 2010-12-14 CA CA2785117A patent/CA2785117C/en active Active
- 2010-12-14 WO PCT/EP2010/069654 patent/WO2011076621A2/de active Application Filing
- 2010-12-14 DK DK10790565.5T patent/DK2515886T3/en active
- 2010-12-14 EP EP10790565.5A patent/EP2515886B1/de active Active
- 2010-12-14 BR BR112012017168-2A patent/BR112012017168B1/pt active IP Right Grant
- 2010-12-14 MX MX2012007214A patent/MX350357B/es active IP Right Grant
- 2010-12-14 JP JP2012545226A patent/JP6083734B2/ja active Active
- 2010-12-14 AU AU2010335309A patent/AU2010335309B2/en active Active
- 2010-12-14 ES ES10790565.5T patent/ES2670227T3/es active Active
- 2010-12-14 PL PL10790565T patent/PL2515886T3/pl unknown
- 2010-12-14 NO NO10790565A patent/NO2515886T3/no unknown
-
2018
- 2018-05-25 CY CY20181100570T patent/CY1120283T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013515025A (ja) | 2013-05-02 |
CN102711744B (zh) | 2014-06-25 |
CA2785117A1 (en) | 2011-06-30 |
CA2785117C (en) | 2016-12-06 |
EP2515886A2 (de) | 2012-10-31 |
MX2012007214A (es) | 2012-09-12 |
AU2010335309A1 (en) | 2012-07-19 |
US8962014B2 (en) | 2015-02-24 |
EP2515886B1 (de) | 2018-04-11 |
WO2011076621A2 (de) | 2011-06-30 |
DK2515886T3 (en) | 2018-06-14 |
WO2011076621A3 (de) | 2012-02-09 |
PT2515886T (pt) | 2018-05-23 |
JP6083734B2 (ja) | 2017-02-22 |
KR20120128606A (ko) | 2012-11-27 |
PL2515886T3 (pl) | 2018-08-31 |
BR112012017168A2 (pt) | 2018-05-02 |
BR112012017168B1 (pt) | 2022-03-15 |
AU2010335309B2 (en) | 2015-08-20 |
CY1120283T1 (el) | 2019-07-10 |
KR101674240B1 (ko) | 2016-11-08 |
MX350357B (es) | 2017-09-05 |
US20130261571A1 (en) | 2013-10-03 |
CN102711744A (zh) | 2012-10-03 |
ES2670227T3 (es) | 2018-05-29 |